Rebecca S Lash1,2, Janice F Bell1, Richard J Bold1,3, Jill G Joseph1, Rosemary D Cress4,5, Ted Wun6, Ann M Brunson6, Patrick S Romano7. 1. Betty Irene Moore School of Nursing, University of California, Davis, Sacramento. 2. Department of Nursing Research and Education, University of California, Los Angeles Health System; Los Angeles. 3. Division of Surgical Oncology, UC Davis School of Medicine, Sacramento. 4. Cancer Registry of Greater California, Public Health Institute, Sacramento. 5. Department of Public Health Sciences, UC Davis School of Medicine, Davis. 6. Center for Oncology Hematology, Division of Hematology Oncology, UC Davis School of Medicine, Sacramento. 7. Division of General Internal Medicine and Center for Health care Policy and Research, UC Davis School of Medicine, Sacramento.
Abstract
BACKGROUND: Improving the quality of cancer care and reducing preventable health system use are goals of increasing importance to health practitioners and policy makers. Emergency department (ED) visits are often cited as a source of preventable health system use, however, few studies have described the incidence of ED use by recently diagnosed cancer patients in population-based samples, and no study has addressed the full spectrum of cancer types. OBJECTIVE: To describe ED use by recently diagnosed cancer patients. METHODS: California Office of Statewide Health Planning and Development data and the California Cancer Registry were used to describe ED use in the year after a cancer diagnosis (2009-2010). The incidence of ED use was tabulated by cancer type. Logistic regression and recycled predictions were used to examine ED use adjusting for confounding factors. RESULTS: Most ED visits (68%) occurred within 180 days of diagnosis. The incidence of ED use for all cancer types examined was 17% within 30 days, 35% within 180 days and 44% within 365 days of diagnosis. ED use varied by cancer type (5%-39% within 30 days of diagnosis; 14% -62% within 180 days; and 22%-69% within 365 days). Patterns of ED use by cancer type remained similar after accounting for demographic and socioeconomic factors. LIMITATIONS: Those common to administrative and registry datasets. Specifically, we were unable to account for ED visits in relation to cancer treatment dates and comorbid conditions. CONCLUSIONS: Cancer patients use EDs at higher rates than previously reported, with considerable variability by cancer type. Future research should examine reasons for ED visits by cancer type and identify predictors of ED use, including treatment and comorbid conditions.
BACKGROUND: Improving the quality of cancer care and reducing preventable health system use are goals of increasing importance to health practitioners and policy makers. Emergency department (ED) visits are often cited as a source of preventable health system use, however, few studies have described the incidence of ED use by recently diagnosed cancer patients in population-based samples, and no study has addressed the full spectrum of cancer types. OBJECTIVE: To describe ED use by recently diagnosed cancer patients. METHODS: California Office of Statewide Health Planning and Development data and the California Cancer Registry were used to describe ED use in the year after a cancer diagnosis (2009-2010). The incidence of ED use was tabulated by cancer type. Logistic regression and recycled predictions were used to examine ED use adjusting for confounding factors. RESULTS: Most ED visits (68%) occurred within 180 days of diagnosis. The incidence of ED use for all cancer types examined was 17% within 30 days, 35% within 180 days and 44% within 365 days of diagnosis. ED use varied by cancer type (5%-39% within 30 days of diagnosis; 14% -62% within 180 days; and 22%-69% within 365 days). Patterns of ED use by cancer type remained similar after accounting for demographic and socioeconomic factors. LIMITATIONS: Those common to administrative and registry datasets. Specifically, we were unable to account for ED visits in relation to cancer treatment dates and comorbid conditions. CONCLUSIONS: Cancer patients use EDs at higher rates than previously reported, with considerable variability by cancer type. Future research should examine reasons for ED visits by cancer type and identify predictors of ED use, including treatment and comorbid conditions.
Authors: Michael J Hassett; A James O'Malley; Juliana R Pakes; Joseph P Newhouse; Craig C Earle Journal: J Natl Cancer Inst Date: 2006-08-16 Impact factor: 13.506
Authors: Hanna K Sanoff; William R Carpenter; Janet Freburger; Ling Li; Kun Chen; Leah L Zullig; Richard M Goldberg; Maria J Schymura; Deborah Schrag Journal: Cancer Date: 2012-01-31 Impact factor: 6.860
Authors: Ravi K Goyal; Stephanie B Wheeler; Racquel E Kohler; Kristen H Lich; Ching-Ching Lin; Katherine Reeder-Hayes; Anne-Marie Meyer; Deborah K Mayer Journal: N C Med J Date: 2014 Jul-Aug
Authors: Arthur S Hong; Danh Q Nguyen; Simon Craddock Lee; D Mark Courtney; John W Sweetenham; Navid Sadeghi; John V Cox; Hannah Fullington; Ethan A Halm Journal: JCO Oncol Pract Date: 2021-05-26
Authors: Lilla Prenek; Klára Csupor; Péter Beszterczán; Krisztina Boros; Erika Kardos; András Vorobcsuk; Miklós Egyed; Ádám Kellner; Péter Rajnics; Csaba Varga Journal: Int J Emerg Med Date: 2021-05-07